- Consumer Products
- Latest 105.57
- Currency US$
- Change 1.04
- Percent Change 0.995 %
- Volume 2,236,894
- Thu May 23, 2013 3:25 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Apr 23||$1.75||Jul 25||$1.68|
12 months ended May 23, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.